Corrigendum to “Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer” [Eur. J. Med. Chem. 242 (2022): 114701]

IF 5.9 2区医学 Q1 CHEMISTRY, MEDICINAL

European Journal of Medicinal Chemistry Pub Date : 2025-07-20 DOI:10.1016/j.ejmech.2025.117984

Limeng Wu, Wenjie Liu, Yaoguang Huang, Chengze Zhu, Qun Ma, Qiong Wu, Liting Tian, Xiangling Feng, Mingyue Liu, Nan Wang, Xiangbo Xu, Xin Liu, Chang Xu, Jingsong Qiu, Zihua Xu, Wenwu Liu, Qingchun Zhao

引用次数: 0

Abstract

The authors regret an error during the organization of Scheme 2. and Fig. 6. in this published article. The author's carelessness during the drawing process resulted in the loss of N atoms in the compound structure and errors in the images and numbering. The corrected Scheme 2. and Fig. 6 are shown here. This correction does not change the conclusions of the article in any way. We sincerely apologize for any inconvenience caused.

查看原文本刊更多论文

“作为治疗癌症的高效CDK2/9抑制剂的他克林衍生物的发展和构效关系”的勘误表[欧洲]。中华医学杂志，2014,22 (2):444 - 444 [j]

作者对方案2组织过程中出现的错误表示遗憾。图6。在这篇发表的文章中。由于作者在绘制过程中的疏忽，导致化合物结构中N原子的丢失，图像和编号出现错误。修正方案2。和图6所示。这一更正不会以任何方式改变文章的结论。对于由此造成的不便，我们深表歉意。下载：下载高分辨率图片（177KB）下载：下载全尺寸图片

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Medicinal Chemistry 化学-医药化学

CiteScore

11.70

自引率

9.00%

发文量

863

审稿时长

29 days

期刊介绍： The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.